Misoprostol Tablet
Product Images NDC 43386-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Misoprostol (NDC 43386-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5df595d7 0e14 4d69 Be64 06e8a992406b 01

5df595d7 0e14 4d69 Be64 06e8a992406b 01
This is a chemical formula representing a compound with a molecular weight of 382.5 g/mol. The compound is named "Methyl 11a, 16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate."*
FDA Label Image

5df595d7 0e14 4d69 Be64 06e8a992406b 02

5df595d7 0e14 4d69 Be64 06e8a992406b 02
This text is a warning label and instructions on how to store and use Misoprostol tablets. It advises not to store the tablets in a dry area, to only use them as directed, and to dispense them in a child-resistant container. It also mentions that the tablets may cause serious complications or miscarriage and should not be used by pregnant women unless at high risk, and only under the guidance of a medical professional. The tablets contain 100 meg of Misoprostol and are manufactured by Lupin Pharmaceuticals.*
FDA Label Image

5df595d7 0e14 4d69 Be64 06e8a992406b 03

5df595d7 0e14 4d69 Be64 06e8a992406b 03
This text provides important information regarding the storage, usage, and concerns associated with the medication Misoprostol, which comes in a tablet form. It should be stored at a temperature of 20 to 25°C (68° to 77°F), in a dry area, and away from pregnant women. Women not at high risk of pregnancy-related complications should not use this medication. Each tablet contains 200 mg of Misoprostol. The enclosed literature should be reviewed for dosage and usage instructions. It is recommended that pharmacists dispense this medication in child-resistant containers with the patient leaflet attached.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.